Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Third Quarter 2024 Earnings: EPS: Ft203 (vs Ft294 in 3Q 2023)

BUSE:RICHTER
Source: Shutterstock

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) Third Quarter 2024 Results

Key Financial Results

  • Revenue: Ft216.7b (up 15% from 3Q 2023).
  • Net income: Ft37.1b (down 32% from 3Q 2023).
  • Profit margin: 17% (down from 29% in 3Q 2023). The decrease in margin was driven by higher expenses.
  • EPS: Ft203 (down from Ft294 in 3Q 2023).
earnings-and-revenue-growth
BUSE:RICHTER Earnings and Revenue Growth November 14th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Earnings Insights

Looking ahead, revenue is forecast to grow 9.0% p.a. on average during the next 3 years, compared to a 7.4% growth forecast for the Pharmaceuticals industry in Europe.

Performance of the market in Hungary.

The company's shares are down 2.2% from a week ago.

Risk Analysis

It is worth noting though that we have found 1 warning sign for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt that you need to take into consideration.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.